Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 5Stomatitis 3Head and Neck Neoplasms 3Fatigue 3Colorectal Neoplasms 3Pain 2Multiple Myeloma 2Lung Neoplasms 2Carcinoma, Hepatocellular 2Ulcer 1Trauma, Nervous System 1Spondylitis, Ankylosing 1Skin Neoplasms 1Schwannomatosis 1Rectal Neoplasms 1Psoriasis 1Pleural Effusion, Malignant 1Pancreatic Cyst 1Ovarian Neoplasms 1Non-functioning Pituitary Adenoma 1Neurofibromatosis 1 1Neurilemmoma 1Neoplasms 1Myelodysplastic Syndromes 1Metastatic Non-Squamous Non-Small Cell Lung Cancer 1Mesothelioma 1Malignant Neoplasm of Colorectum 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma 1

Interventions

sotrastaurin 1sodium luminolate 1ixekizumab 1baricitinib 1abrocitinib 1Vaccines 1Saline Solution 1Herpes Zoster Vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Psoriasis × Saline Solution × Clear all
NCT02538341 2021-11-23

Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)

University of Alabama at Birmingham

Phase 2 Completed
617 enrolled 17 charts

Arthritis, Arthritis, Rheumatoid, Crohn Disease, Psoriasis, Spondylitis, Ankylosing, Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡